EVIO, Inc. announced that it has received $0.157 million in funding
February 03, 2021
Share
EVIO, Inc. (OTCPK:EVIO) announced that it has entered into agreements and receive 8% convertible promissory note with existing note holder in the amount $174,445 on February 4, 2021. The company paid $7,000 to legal expenses. The company issued note at an original issue discount of $17,445. The note maybe prepaid based on the following, 0-90 days, 125% of principal amount, 91-180, 135% of principal amount, 181 and above, 150% of principal amount. At any time after the original issue date until the note is no longer outstanding, the note shall be convertible at the lower of $0.006 or 70% of the lowest daily trade price in the twenty trading days prior to the conversion date.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.